Case number 1:23-cv-01144
Fresenius Kabi USA, LLC et al v. Caplin Steriles Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 12, 2024 | 11 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Notice of Voluntary Dismissal)(mdb) (Entered: 03/12/2024) (0) |
| Mar 11, 2024 | 10 | NOTICE of Voluntary Dismissal by Fresenius Kabi Deutschland GmbH, Fresenius Kabi USA, LLC (Farnan, Michael) (Entered: 03/11/2024) (1) |
| Mar 11, 2024 | N/A | CASE CLOSED (dlw) (Entered: 03/11/2024) (0) |
| Feb 21, 2024 | N/A | Pro Hac Vice Attorney John Bennett for Fresenius Kabi Deutschland GmbH and Fresenius Kabi USA, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 02/21/2024) (0) |
| Feb 15, 2024 | N/A | Pro Hac Vice Attorneys Ayyan S. Zubair and Shaobo Zhu for Fresenius Kabi Deutschland GmbH and Fresenius Kabi USA, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 02/15/2024) (0) |
| Feb 14, 2024 | N/A | SO ORDERED re 8 MOTION for Pro Hac Vice Appearance of Attorney John Bennett, Shaobo Zhu, and Ayyan Zubair filed by Fresenius Kabi USA, LLC, Fresenius Kabi Deutschland GmbH. ORDERED by Judge Maryellen Noreika on 2/14/2024. (dlw) (Entered: 02/14/2024) (0) |
| Feb 13, 2024 | 8 | MOTION for Pro Hac Vice Appearance of Attorney John Bennett, Shaobo Zhu, and Ayyan Zubair - filed by Fresenius Kabi Deutschland GmbH, Fresenius Kabi USA, LLC. (Farnan, Brian) (Entered: 02/13/2024) (4) |
| Feb 13, 2024 | 9 | Pro Hac Vice Fee - Credit Card Payment received for John Bennett, Shaobo Zhu, and Ayyan Zubair. ( re 8 MOTION for Pro Hac Vice Appearance of Attorney John Bennett, Shaobo Zhu, and Ayyan Zubair )( Payment of $ 150, receipt number ADEDC-4337777).(Farnan, Brian) (Entered: 02/13/2024) (0) |
| Feb 7, 2024 | 7 | Unopposed MOTION for Extension of Time to Serve Complaint - filed by Fresenius Kabi Deutschland GmbH, Fresenius Kabi USA, LLC. (Attachments: # 1 Text of Proposed Order)(Farnan, Michael) Modified on 2/7/2024 (dlw). (Entered: 02/07/2024) (0) |
| Feb 7, 2024 | N/A | SO ORDERED re 7 Unopposed MOTION for Extension of Time to Serve Complaint - IT IS HEREBY ORDERED that the unopposed motion is GRANTED. The deadline to serve the complaint is extended until 3/11/2024. ORDERED by Judge Maryellen Noreika on 2/7/2024. (dlw) (Entered: 02/07/2024) (0) |
| Jan 5, 2024 | N/A | SO ORDERED re 6 UNOPPOSED MOTION for Extension of Time to Serve Complaint - IT IS HEREBY ORDERED that the unopposed motion is GRANTED. The deadline to serve the complaint is extended until 2/9/2024. ORDERED by Judge Maryellen Noreika on 1/5/2024. (dlw) (Entered: 01/05/2024) (0) |
| Jan 4, 2024 | 6 | UNOPPOSED MOTION for Extension of Time to Serve Complaint - filed by Fresenius Kabi Deutschland GmbH, Fresenius Kabi USA, LLC. (Attachments: # 1 Text of Proposed Order)(Farnan, Michael) Modified on 1/5/2024 (dlw). (Entered: 01/04/2024) (0) |
| Oct 18, 2023 | N/A | Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (nms) (Entered: 10/18/2023) (0) |
| Oct 12, 2023 | 1 | Complaint* (1) |
| Oct 12, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) (Entered: 10/13/2023) (3) |
| Oct 12, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/01/2023. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 3/1/2026. (vfm) (Entered: 10/13/2023) (2) |
| Oct 12, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,828,787 B2 ;US 7,857,802 B2. (vfm) (Entered: 10/13/2023) (1) |
| Oct 12, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Fresenius Kabi AG for Fresenius Kabi Deutschland GmbH; Corporate Parent Fresenius Kabi Pharmaceuticals Holding, LLC for Fresenius Kabi USA, LLC. Fresenius Kabi Pharmaceuticals Holding, LLC is wholly-owned by Fresenius Kabi AG; and Fresenius Kabi AG is wholly-owned by Fresenius SE & Co. KGaA - filed by Fresenius Kabi Deutschland GmbH, Fresenius Kabi USA, LLC. (vfm) (Entered: 10/13/2023) (2) |
| Oct 12, 2023 | N/A | No Summons Issued. (vfm) (Entered: 10/13/2023) (0) |
